Matthew Taylor
Stock Analyst at Jefferies
(4.37)
# 1,244
Out of 4,509 analysts
662
Total ratings
54.6%
Success rate
6.9%
Average return
Main Sectors:
Stocks Rated by Matthew Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GEHC GE HealthCare Technologies | Maintained: Buy | $90 | $65.31 | +37.80% | 12 | Jul 13, 2026 | |
| RMD ResMed | Rated: Hold | $245 → $225 | $198.50 | +13.35% | 16 | Jul 10, 2026 | |
| BSX Boston Scientific | Rated: Buy | $100 → $67 | $44.65 | +50.06% | 51 | Jun 24, 2026 | |
| SYK Stryker | Maintained: Buy | $465 → $455 | $331.45 | +37.28% | 35 | Jun 18, 2026 | |
| EW Edwards Lifesciences | Maintained: Buy | $102 | $91.79 | +11.12% | 68 | May 27, 2026 | |
| MDT Medtronic | Rated: Hold | $95 | $83.57 | +13.68% | 40 | Apr 24, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $145 → $135 | $92.11 | +46.56% | 42 | Apr 17, 2026 | |
| LNTH Lantheus Holdings | Reiterated: Buy | $105 → $110 | $105.39 | +4.37% | 13 | Mar 18, 2026 | |
| PODD Insulet | Reiterated: Buy | $400 | $162.06 | +146.82% | 30 | Feb 19, 2026 | |
| DXCM DexCom | Reiterated: Buy | $112 | $76.35 | +46.69% | 36 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $22.57 | -15.82% | 34 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $115 | $79.75 | +44.20% | 30 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $16.25 | +195.38% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $15 → $12 | $10.80 | +11.11% | 3 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $22.38 | -15.10% | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $130 → $110 | $94.08 | +16.92% | 28 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $79 → $80 | $82.98 | -3.59% | 13 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $61 → $63 | $87.90 | -28.33% | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $17.85 | +56.86% | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $5.25 | n/a | 4 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $407.12 | n/a | 24 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $305 → $255 | $153.83 | n/a | 29 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $215 → $145 | $136.40 | n/a | 32 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33.00 → $34.50 | $15.99 | n/a | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $16 → $15 | $15.15 | n/a | 23 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.5 → $6 | $5.29 | n/a | 3 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $18.58 | n/a | 16 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $105 | $42.41 | n/a | 1 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $14 | $3.82 | n/a | 1 | Jan 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 364.00 → CHF 255.00 | $206.20 | n/a | 13 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $230 | $318.94 | n/a | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $5.5 | $8.10 | n/a | 2 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $175.80 | n/a | 2 | Feb 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €49.00 | $24.09 | n/a | 21 | Jan 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $35.56 | n/a | 1 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $1.5 → $1 | $7.95 | n/a | 9 | Mar 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $16 | $12.78 | n/a | 2 | Jul 19, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $2.5 | $0.000001 | n/a | 2 | May 12, 2016 |
GE HealthCare Technologies
Jul 13, 2026
Maintained: Buy
Price Target: $90
Current: $65.31
Upside: +37.80%
ResMed
Jul 10, 2026
Rated: Hold
Price Target: $245 → $225
Current: $198.50
Upside: +13.35%
Boston Scientific
Jun 24, 2026
Rated: Buy
Price Target: $100 → $67
Current: $44.65
Upside: +50.06%
Stryker
Jun 18, 2026
Maintained: Buy
Price Target: $465 → $455
Current: $331.45
Upside: +37.28%
Edwards Lifesciences
May 27, 2026
Maintained: Buy
Price Target: $102
Current: $91.79
Upside: +11.12%
Medtronic
Apr 24, 2026
Rated: Hold
Price Target: $95
Current: $83.57
Upside: +13.68%
Abbott Laboratories
Apr 17, 2026
Reiterated: Buy
Price Target: $145 → $135
Current: $92.11
Upside: +46.56%
Lantheus Holdings
Mar 18, 2026
Reiterated: Buy
Price Target: $105 → $110
Current: $105.39
Upside: +4.37%
Insulet
Feb 19, 2026
Reiterated: Buy
Price Target: $400
Current: $162.06
Upside: +146.82%
DexCom
Feb 13, 2026
Reiterated: Buy
Price Target: $112
Current: $76.35
Upside: +46.69%
Feb 12, 2026
Reiterated: Hold
Price Target: $19
Current: $22.57
Upside: -15.82%
Jan 8, 2026
Reiterated: Buy
Price Target: $105 → $115
Current: $79.75
Upside: +44.20%
Nov 7, 2025
Reiterated: Buy
Price Target: $48
Current: $16.25
Upside: +195.38%
Oct 3, 2025
Maintained: Hold
Price Target: $15 → $12
Current: $10.80
Upside: +11.11%
Aug 25, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $22.38
Upside: -15.10%
Aug 7, 2025
Maintained: Hold
Price Target: $130 → $110
Current: $94.08
Upside: +16.92%
Aug 7, 2025
Maintained: Buy
Price Target: $79 → $80
Current: $82.98
Upside: -3.59%
Aug 7, 2025
Maintained: Buy
Price Target: $61 → $63
Current: $87.90
Upside: -28.33%
Aug 5, 2025
Maintained: Buy
Price Target: $28
Current: $17.85
Upside: +56.86%
Jun 4, 2025
Maintained: Buy
Price Target: $18
Current: $5.25
Upside: n/a
May 2, 2025
Maintained: Hold
Price Target: n/a
Current: $407.12
Upside: n/a
May 1, 2025
Maintained: Buy
Price Target: $305 → $255
Current: $153.83
Upside: n/a
May 1, 2025
Reiterated: Hold
Price Target: $215 → $145
Current: $136.40
Upside: n/a
Apr 28, 2025
Maintained: Buy
Price Target: $33.00 → $34.50
Current: $15.99
Upside: n/a
Apr 14, 2025
Upgraded: Buy
Price Target: $16 → $15
Current: $15.15
Upside: n/a
Mar 4, 2025
Reiterated: Sell
Price Target: $0.5 → $6
Current: $5.29
Upside: n/a
Jul 16, 2024
Reiterated: Buy
Price Target: $50 → $48
Current: $18.58
Upside: n/a
Feb 1, 2024
Maintained: Hold
Price Target: $105
Current: $42.41
Upside: n/a
Jan 19, 2024
Initiated Coverage: Buy
Price Target: $14
Current: $3.82
Upside: n/a
Oct 28, 2022
Maintained: Hold
Price Target: CHF 364.00 → CHF 255.00
Current: $206.20
Upside: n/a
Oct 12, 2022
Initiated Coverage: Buy
Price Target: $230
Current: $318.94
Upside: n/a
Mar 1, 2022
Maintained: Hold
Price Target: $7 → $5.5
Current: $8.10
Upside: n/a
Feb 7, 2022
Upgraded: Buy
Price Target: n/a
Current: $175.80
Upside: n/a
Jan 25, 2022
Maintained: Buy
Price Target: €49.00
Current: $24.09
Upside: n/a
Dec 6, 2019
Maintained: Hold
Price Target: n/a
Current: $35.56
Upside: n/a
Mar 8, 2018
Maintained: Sell
Price Target: $1.5 → $1
Current: $7.95
Upside: n/a
Jul 19, 2017
Maintained: Hold
Price Target: $17 → $16
Current: $12.78
Upside: n/a
May 12, 2016
Reiterated: Hold
Price Target: $5 → $2.5
Current: $0.000001
Upside: n/a